Internal stimuli-responsive nanocarriers for controlled anti-cancer drug release: a review

Table S1: Nanostructured biomolecules approved or in clinical trials for cancer therapy [8]. Table S2: examples of pH-responsive medication delivery systems. Table S3. Nanocarriers that respond to enzymes for cancer theragnostic. Table S4. Nanocarriers with redox response for cancer theranostics [108]. Table S5: Representative hypoxia-responsive nanocarriers [108]. Table S6: Drug release effects of various types of hypoxia-sensitive NPs.